PRTODAY / NewswireToday Free press release distribution service network

Agency / Source: AnaSpec, Inc.

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!

AnaSpec Introduces Newest GO™ Peptides - Exendins - Along with a host of popular Exendin peptides, AnaSpec’s GO™ Peptides line includes Fluorescein-Trp25-Exendin-4 (FLEX) and [Cys(HiLyteFluor 647 C2 maleimide)]-Exendin-4 - two exendin peptides that are not immediately available anywhere else
AnaSpec Introduces Newest GO™ Peptides - Exendins

 

NewswireToday - /newswire/ - San Jose, CA, United States, 02/27/2009 - Along with a host of popular Exendin peptides, AnaSpec’s GO™ Peptides line includes Fluorescein-Trp25-Exendin-4 (FLEX) and [Cys(HiLyteFluor 647 C2 maleimide)]-Exendin-4 - two exendin peptides that are not immediately available anywhere else.

   
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

AnaSpec has added a wide selection of Exendin peptides to it’s GO™ Peptides line of on-demand peptides. Along with a host of popular Exendin peptides, AnaSpec’s GO™ Peptides line includes Fluorescein-Trp25-Exendin-4 (FLEX) and [Cys(HiLyteFluor 647 C2 maleimide)]-Exendin-4 - two exendin peptides that are not immediately available anywhere else.

Fluorescein-Trp25-Exendin-4 (FLEX) is Exendin-4 with a fluorescein covalently attached to Trp at position 25. Useful for binding and characterization studies of the human GLP-1 receptor, FLEX is equipotent to GLP-1 (7-36)-amide and Exendin-4 as an inhibitor of [125I]-GLP-1 binding to the human GLP-1 receptor stably expressed in CHO cells.1 [Cys(HiLyte Fluor™ 647 C2 maleimide)]-Exendin -4 is Exendin-4 with an additional Cys added to the N-terminus. AnaSpec’s patented HiLyte Fluor 647 (Ex/Em=650 nm/675 nm) is attached to the Cys thiol moiety.

Exendin-3 and Exendin-4 are 39-amino acid peptides from exocrine glands that share about 50% sequence identity to Glucagon-Like-Peptide-1 (GLP-1) and are potent GLP-1R agonists. 2,3 Exendin-3 stimulates increases in cellular cAMP and amylase release from dispersed guinea pig pancreatic acini.4 Exendin-4 was originally isolated from the saliva of the lizard Heloderma suspectum. It is an insulinotropic agent which improves glucose tolerance in humans and animals with diabetes. It increases insulin sensitivity via a PI-3-kinase-dependent mechanism. In the human fetal pancreas, the proliferation and differentiation of endocrine precursor cells into insulin-producing ß-cells can be positively regulated by Exendin-4.5 Exendin-4 is an agonist and Exendin (9-39) is an antagonist of the action of GLP-I (7-36) amide on arterial blood pressure and heart rate.6

About AnaSpec

AnaSpec (anaspec.com) is a leading provider of integrated proteomics solutions to the world’s largest biotech, pharmaceutical, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.

References:
1. Chicchi GG. et al. Peptides 18, 319 (1997).
2. Goke, R. et al. J. Biol. Chem. 268, 19650 (1993).
3. Thorens, B. et al. Diabetes 42, 1678 (1993).
4. Eng, J. J. Biol. Chem. 265, 20259 (1990).
5. Movassat, J. et al. J. Clin. Endo. Metab. 87, 4775 (2002).
6. Barragan, JM. Regul. Peptides 67, 63 (1994).

 
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces Newest GO™ Peptides - Exendins

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Ping Yang 
408-452-5055 ping[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSS
AddThis press release: AnaSpec Introduces Newest GO™ Peptides - ExendinsAdd Pharma/BioTech/Nutrition News to My MSNAdd Pharma/BioTech/Nutrition News to My Yahoo!Add NewswireToday Pharma/BioTech/Nutrition Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner Twitter /NewswireToday

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!


Read Latest Articles From AnaSpec, Inc. / Company Profile



AnaSpec Announces Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection
AnaSpec Announces Antibodies Against the Hexa-His and GFP Tags
AnaSpec Introduces SensoLyte® Factor Xa Activity Assays - Industry’s First Fluorimetric Kits
AnaSpec Highlights Atrial Natriuretic Peptides in GO® Collection
AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay
AnaSpec Offers Speedy 28-day Custom Polyclonal Antibody Service
AnaSpec Launches Custom Peptide Synthesis Services
AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit
AnaSpec Highlights its Proprietary HiLyte Fluor™ Dye Collection
AnaSpec Highlights Calcein AM for Live Cell Staining
AnaSpec Expands SensoLyte® 520 Renin Assay Kits Collection
AnaSpec Introduces SensoLyte® Deubiquitination Assay Kit
AnaSpec Includes Citrullinated Histone in GO® Peptides Collection
AnaSpec Introduces Industry’s First Anti-MOG ELISA Assay Kits
AnaSpec Provides Industry’s Largest Collection of Anti-Tau Antibodies

Reserve This Permanent SPACE

Your LOGO permanently HERE on Newswire Today most visited Page start at $295 per month

 
Sponsored Links


Visit  Gripsell

Visit  NAMSR - National Assoc. of Medical Sales Rep










 
  ©2012 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri- bution today investor relation successful internet entrepreneur free newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)